| Literature DB >> 33952233 |
Erin R Kulick1,2, Trevor Alvord3,4, Michelle Canning3,4, Mitchell S V Elkind3,4, Bernard P Chang5, Amelia K Boehme3,4.
Abstract
BACKGROUND: Influenza may be associated with increased stroke and myocardial infarction (MI) risk. We hypothesized that risk of stroke and MI after influenza-like illness (ILI) would be higher in patients in New York State. We additionally assessed whether this relationship differed across a series of sociodemographic factors.Entities:
Keywords: Cardiovascular diseases; Case-crossover; Health disparities; Influenza; Myocardial infarction; Stroke
Mesh:
Year: 2021 PMID: 33952233 PMCID: PMC8097921 DOI: 10.1186/s12889-021-10916-4
Source DB: PubMed Journal: BMC Public Health ISSN: 1471-2458 Impact factor: 3.295
ICD-9 Codes used to define Influenza-Like Illness (ILI)
| 079.89 | Viral infection NEC | 466 | Acute bronchitis and bronchiolitis |
| 079.99 | Viral infection NOS | 466.0 | Acute bronchitis |
| 460 | Acute nasopharyngitis | 466.1 | Acute bronchiolitis |
| 462 | Acute pharyngitis | 466.19 | Acute bronchiolitis due to other infectious organism |
| 464 | Acute laryngitis and tracheitis | 478.9 | Other and unspecified diseases of upper respiratory tract |
| 464.0 | Acute laryngitis | 480 | Viral pneumonia |
| 464.1 | Acute tracheitis | 487 | Influenza |
| 464.10 | Acute tracheitis w/o obstruction | 487.0 | Influenza with pneumonia |
| 464.2 | Acute laryngotracheitis | 487.1 | Influenza with other respiratory manifestation |
| 464.20 | Acute laryngotracheitis w/o obstruction | 487.8 | Influenza with other manifestation |
| 465 | Upper respiratory infection, multiple or unspecified sites | 490 | Bronchitis not specified as acute or chronic |
| 465.0 | Acute laryngopharyngitis | 780.6 | Fever |
| 465.8 | Upper respiratory infection of multiple sites | 784.1 | Throat pain |
| 465.9 | Upper respiratory infection of unspecified sites | 786.2 | Cough |
Adapted from Eick-Cost AA, Hunt DJ. 2015 Assessment of ICD-9-based case definitions for influenza-like illness surveillance. MSMR
Fig. 1Case-Crossover Study Design. Describes the case-crossover study design used in this analysis and compares the relationship between each patient’s case window (the time -period preceding the cardiovascular event) to their control windows (constructed using the same calendar dates from the previous two years)
Baseline characteristics of patients with and without exposure to Influenza-Like-Illness in 365-days prior to cardiovascular event
| Ischemic Stroke | Myocardial Infarction ( | |||
|---|---|---|---|---|
| Cases with exposure to ILI | Cases without ILI | Cases with exposure to ILI | Cases without ILI | |
| Age (years) | 65.6 | 72.2 | 66.9 | 71.3 |
| Standard deviation (range) | 16.4 (18–101) | 14.6 (18–104) | 15.3 (18–109) | 14.4 (18–111) |
| Women, N (%) | 1037 (51.6%) | 16,213 (51.1%) | 1714 (45.4%) | 21,372 (43.3%) |
| Race, N (%) | ||||
| White | 910 (45.6%) | 19,675 (62.3%) | 2064 (54.9%) | 34,243 (69.7%) |
| Black | 1099 (54.7%) | 12,058 (37.7%) | 1709 (45.3%) | 15,078 (30.3%) |
| Residential Geography, N (%) | ||||
| Urban | 1795 (89.4%) | 28,287 (89.1%) | 3214 (85.2%) | 42,736 (86.7%) |
| Rural | 214 (10.6%) | 3446 (10.9%) | 559 (14.8%) | 6585 (13.3%) |
Cumulative odds ratios and 95% CI for ILI with risk of cardiovascular event
| Hospitalization for ILI | Ischemic Stroke | Myocardial Infarction | ||
|---|---|---|---|---|
| OR | 95% CI | OR | 95% CI | |
| 0–15 days before event | 1.39* | 1.09, 1.77 | 1.24* | 1.06, 1.44 |
| 0–30 days before event | 1.48* | 1.25, 1.76 | 1.07 | 0.96, 1.20 |
| 0–60 days before event | 1.48* | 1.29, 1.69 | 1.04 | 0.95, 1.14 |
| 0–90 days before event | 1.59* | 1.42, 1.78 | 1.07 | 0.99, 1.15 |
| 0–180 days before event | 1.68* | 1.53, 1.85 | 1.21* | 1.14, 1.29 |
| 0–365 days before event | 1.69* | 1.56, 1.83 | 1.48* | 1.41, 1.57 |
*Indicates Statistical Significance at p < 0.05.
Effect Modification of Association between ILI and Ischemic stroke by demographic and sociodemographic characteristics
| Residential Geography | Sex | Race | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Urban | Rural | Men | Women | Black | White | ||||
| OR (95%CI) | OR (95%CI) | OR (95%CI) | OR (95%CI) | OR (95%CI) | OR (95%CI) | ||||
| 0–15 days before event | 1.38 (1.08, 1.78) | 1.43 (0.63, 3.22) | 0.98 | 1.57 (1.13, 2.18) | 1.22 (0.85, 1.72) | 0.82 | 1.40 (0.88, 2.24) | 1.43 (0.99, 2.04) | 0.79 |
| 0–30 days before event | 1.45 (1.21, 1.75) | 1.65 (1.05, 2.59) | 0.10* | 1.82 (1.43, 2.30) | 1.17 (0.91, 1.51) | 0.04* | 1.34 (0.95, 1.89) | 1.47 (1.15, 1.89) | 0.56 |
| 0–60 days before event | 1.48 (1.28, 1.70) | 1.51 (1.07, 2.12) | 0.93 | 1.65 (1.37, 1.98) | 1.33 (1.10, 1.60) | 0.11 | 1.36 (1.05, 1.76) | 1.49 (1.23, 1.80) | 0.64 |
| 0–90 days before event | 1.56 (1.38, 1.76) | 1.79 (1.33, 2.41) | 0.56 | 1.75 (1.49, 2.06) | 1.45 (1.23, 1.69) | 0.23 | 1.56 (1.25, 1.95) | 1.55 (1.31, 1.82) | 0.36 |
| 0–180 days before event | 1.69 (1.52, 1.87) | 1.63 (1.29, 2.07) | 0.87 | 1.87 (1.63, 2.14) | 1.53 (1.34, 1.74) | 0.08* | 1.71 (1.42, 2.05) | 1.52 (1.33, 1.74) | 0.50 |
| 0–365 days before event | 1.71 (1.57, 1.87) | 1.57 (1.29, 1.91) | 0.51 | 1.73 (1.54, 1.95) | 1.66 (1.49, 1.84) | 0.54 | 1.64 (1.41, 1.92) | 1.56 (1.401, 1.744) | 0.93 |
*Indicates Statistical Significance at p < 0.05
Effect Modification of Association between ILI and Myocardial Infarction by demographic and sociodemographic characteristics
| Residential Geography | Sex | Race | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Urban | Rural | Male | Female | Black | White | ||||
| OR (95%CI) | OR (95%CI) | OR (95%CI) | OR (95%CI) | OR (95%CI) | OR (95%CI) | ||||
| 0–15 days before event | 1.20 (1.01, 1.42) | 1.41 (0.99, 2.01) | 0.26 | 1.15 (0.94, 1.41) | 1.35 (1.07, 1.70) | 0.91 | 1.13 (0.78, 1.62) | 1.63 (1.32, 2.01) | 0.08* |
| 0–30 days before event | 1.02 (0.90, 1.16) | 1.31 (1.01, 1.69) | 0.13 | 1.02 (0.88, 1.19) | 1.14 (0.97, 1.36) | 0.49 | 0.91 (0.69, 1.19) | 1.37 (1.17, 1.60) | 0.003* |
| 0–60 days before event | 0.99 (0.90, 1.09) | 1.28 (1.04, 1.56) | 0.17 | 1.02 (0.90, 1.14) | 1.08 (0.94, 1.23) | 0.71 | 0.87 (0.69, 1.08) | 1.33 (1.18, 1.50) | 0.0002* |
| 0–90 days before event | 1.03 (0.94, 1.12) | 1.25 (1.04, 1.49) | 0.67 | 1.06 (0.96, 1.18) | 1.07 (0.95, 1.20) | 0.75 | 0.91 (0.75, 1.09) | 1.34 (1.21, 1.49) | < 0.01* |
| 0–180 days before event | 1.19 (1.11, 1.28) | 1.31 (1.13, 1.51) | 0.90 | 1.18 (1.09, 1.29) | 1.25 (1.14, 1.37) | 0.91 | 1.10 (0.94, 1.28) | 1.44 (1.32, 1.57) | 0.001* |
| 0–365 days before event | 1.46 (1.37, 1.55) | 1.587 (1.41, 1.79) | 0.56 | 1.43 (1.33, 1.54) | 1.55 (1.43, 1.68) | 0.74 | 1.29 (1.13, 1.46) | 1.69 (1.58, 1.82) | 0.002* |
*Indicates Statistical Significance at p < 0.05.